- Why are vegetarians more likely to suffer from depression than meat eaters?
- Small wireless device implanted between skin and skull helps kill cancer cells
- Will the mRNA vaccine that can cure cancer come out near soon?
- Allogeneic T-cell therapy set for landmark first approval
- Boston University denies that the new COVID strain they made has 80% fatality rate
- A new generation of virus-free CAR-T cell therapy
Chile releases data: Kexing(SINOVAC) COVID-19 vaccine 67% effective
Chile releases data: Kexing(SINOVAC) COVID-19 vaccine 67% effective. Chile releases data on the protective effect of Kexing(SINOVAC) vaccine, which has an effective rate of 67% in preventing symptomatic infections.
On April 16, Chile’s Minister of Health Paris (right) and Chilean Ministry of Health consultant Alaus attended the press conference in Santiago to announce the protection effect data of Kexing vaccine. Issued by Xinhua News Agency (Photo courtesy of the Chilean Ministry of Health)
Xinhua News Agency, Santiago, April 16 (Reporter Yin Nan Zhang Xiaoran) The Chilean Ministry of Health announced on the 16th the results of a real-world study on the protective effects of China’s Kexing COVID-19 vaccine in the country. Studies have shown that the vaccine is 67% effective in preventing symptomatic infections 14 days after the second dose.
Real-world research refers to obtaining evidence of the use value and potential benefits or risks of medical products by collecting patient-related data in the real-world environment.
The consultant of the Chilean Ministry of Health who led the study said that the study showed that the effective rate of Kexing Vaccine for preventing hospitalization 14 days after the second dose was 85%, and the effective rate for preventing entry into the intensive care unit was 89%. The effective rate of preventing death caused by infection is 80%.
On April 16, Chilean Minister of Health Paris attended the press conference in Santiago.
Alaus said that studies have shown that in a highly prevalent environment, the Kexing COVID-19 vaccine can effectively reduce the symptomatic infection and aggravation of COVID-19. This report is a preliminary research result, and the Chilean Ministry of Health will update the report monthly.
Chilean Health Minister Paris said that the study showed that the Kexing COVID-19 vaccine is effective. Chile will continue to promote the large-scale vaccination of the COVID-19 vaccine across the country. The public should continue to strictly abide by various epidemic prevention regulations and not relax self-protection measures such as wearing masks and maintaining social distance.
Chile launched a nationwide large-scale vaccination of the COVID-19 vaccine on February 3. As of the 15th of this month, 7.66 million people in Chile have been vaccinated against the COVID-19 vaccine. The total number of doses in the country is 12.93 million, of which about nine are the COVID-19 vaccines for China’s Kexing.
(source:internet, reference only)